Amelia Monfared, PharmD candidate ’25, has been honored with the Dr. Elliot S. Vesell Award for her abstract in the area of pharmacogenomics. Given by the American College of Clinical Pharmacology (ACCP), the award recognizes Amelia as a top student researcher in the area of pharmacogenomics.

Her project abstract, “Analyzing the Association Between Single Nucleotide Polymorphisms & Combinations of Buprenorphine & Associated Metabolite Concentrations,” resulted from her research from the mentorship of professor Dr. Sam Harirforoosh. Melissa Hoang, PharmD candidate ’25, is listed as a co-author. Amelia has delved into the intricate relationships between genetic variations and the pharmacokinetics of buprenorphine, a critical medication in pain management and opioid dependency treatment.

The project has provided insights that could potentially influence personalized medicine approaches in pharmacotherapy. The project studies the intricate relationships between genetic variations and the pharmacokinetics of buprenorphine, a critical medication in pain management and opioid dependency treatment.

The Dr. Elliot S. Vesell Award includes complimentary registration to the ACCP annual meeting in September, financial support for travel, and an honorarium, allowing Amelia to present her research.